| 英文别名 |
LXH254;Naporafenib;LXH254 free base;15JL80DG6H;N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide;N-[3-[2-(2-hydroxyethoxy)-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-{3-[2-(2-hydroxyethoxy)-6-(morpholin-4-yl)pyridin-4-yl]-4-methylphenyl}-2-(trifluoromethyl)pyridine-4-carboxamide;K81;Naporafenib [INN];NSC-807047;example 1156 [WO2014151616A1];GTPL10658;LXH 254;pan-RAF Kinase Inhibitor LXH254;NVP-LXH254;BCP29080;BL166445;s8745;4-Pyridinecarboxamide, N-[3-[2-(2-hydroxyethoxy)-6-(4-morpholinyl)-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)-;MFCD31657408;DA-75171;compound 15 (PMID: 31059256);ERAS-254;BS-16133;Pan-raf inhibitor LXH254;NSC807047;Raf Family Kinase Inhibitor LXH254;AKOS037648965;1800398-38-2;NAPORAFENIB [USAN];NAPORAFENIB [WHO-DD];LXH254?;LXH 254 [WHO-DD];CHEMBL4583691;4-Pyridinecarboxamide, N-(3-(2-(2-hydroxyethoxy)-6-(4-morpholinyl)-4-pyridinyl)-4-methylphenyl)-2-(trifluoromethyl)-)-;N-[3-[2-(2-Hydroxyethoxy)-6-morpholino-4-pyridyl]-4-methylphenyl]-2-(trifluoromethyl)isonicotinamide;N-(3-(2-(2-hydroxyethoxy)-6-morpholin-4-ylpyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)pyridine-4-carboxamide;Naporafenib (USAN/INN);CS-0043317;UNII-15JL80DG6H;HY-112089;D12831;SCHEMBL16094629;N-{3-[2-(2-hydroxethoxy)-6-(morpholin-4-yl)pyridin-4-yl]-4-methylphenyl}-2-(trifluoromethyl)pyridine-4-carboxamide;EX-A1846;example 1156 (WO2014151616A1);BDBM88120;LXH-254;1800398-38-2 (free base);SY340309;N-(3-(2-(Hydroxyethoxy)-6-(morpholin-4-yl) pyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)pyridine-4-carboxamide;GLXC-20142;US9694016, 1156;AT23218;compound 15 [PMID: 31059256];AC-36207 |
在线客服
专业包装 品类齐全
厂家直发 快捷到货
品牌正品 质量保证
自助下单 尝选无忧
